Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Household Transmission and Clinical Features of SARS-CoV-2 Infections by Age in 2 US Communities

View ORCID ProfileHuong Q. McLean, Carlos G. Grijalva, Kayla E. Hanson, Yuwei Zhu, Jessica E. Deyoe, Jennifer K. Meece, Natasha B. Halasa, James D. Chappell, Alexandra Mellis, Carrie Reed, Edward A. Belongia, H. Keipp Talbot, Melissa A. Rolfes
doi: https://doi.org/10.1101/2021.08.16.21262121
Huong Q. McLean
aMarshfield Clinic Research Institute, Marshfield, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Huong Q. McLean
  • For correspondence: mclean.huong@marshfieldresearch.org
Carlos G. Grijalva
bVanderbilt University Medical Center, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayla E. Hanson
aMarshfield Clinic Research Institute, Marshfield, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuwei Zhu
bVanderbilt University Medical Center, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica E. Deyoe
cCenters for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer K. Meece
aMarshfield Clinic Research Institute, Marshfield, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natasha B. Halasa
bVanderbilt University Medical Center, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James D. Chappell
bVanderbilt University Medical Center, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Mellis
cCenters for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carrie Reed
cCenters for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward A. Belongia
aMarshfield Clinic Research Institute, Marshfield, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Keipp Talbot
bVanderbilt University Medical Center, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa A. Rolfes
cCenters for Disease Control and Prevention, Atlanta, Georgia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

OBJECTIVES Examine age differences in SARS-CoV-2 transmission risk from primary cases and infection risk among household contacts, and symptoms among those with SARS-CoV-2 infection.

METHODS People with SARS-CoV-2 infection in Nashville, Tennessee and central and western Wisconsin and their household contacts were followed daily for 14 days to ascertain symptoms and secondary transmission events. Households were enrolled between April 2020 and April 2021. Secondary infection risks (SIR) by age of the primary case and contacts were estimated using generalized estimating equations.

RESULTS The 226 primary cases were followed by 197 (49%) secondary SARS-CoV-2 infections among 404 household contacts. Age group-specific SIR among contacts ranged from 35% to 53%, with no differences by age. SIR was lower from primary cases aged 12-17 years than from primary cases 18-49 years (risk ratio [RR] 0.42; 95% confidence interval [CI] 0.19-0.92). SIR was 56% and 45%, respectively, among primary case-contact pairs in the same versus different age group (RR 1.54; 95% CI 1.03-2.31). SIR was highest among primary case-contacts pairs aged ≥65 years (77%) and 5-11 years (70%). Among secondary SARS-CoV-2 infections, 19% were asymptomatic; there was no difference in the frequency of asymptomatic infections by age group.

CONCLUSIONS Both children and adults can transmit and are susceptible to SARS-CoV-2 infection. SIR did not vary by age, but further research is needed to understand age-related differences in probability of transmission from primary cases by age.

Competing Interest Statement

NBH reports grants from Sanofi and Quidel. CGG reports grants from Campbell Alliance/Syneos, the National Institutes of Health, the Food and Drug Administration, the Agency for Health Care Research and Quality and Sanofi-Pasteur, and consultation fees from Pfizer, Merck, and Sanofi-Pasteur. Other authors have no conflicts of interest relevant to this article to disclose.

Funding Statement

Funding/Support: This study was supported by the Centers for Disease Control and Prevention, (cooperative agreements IP001078 and IP001083). Dr. Grijalva was supported in part by the National Institute for Allergy and Infectious Diseases (K24 AI148459). The work used REDCap, which is supported by CTSA award No. UL1 TR002243 from the National Center for Advancing Translational Sciences. Role of Funder/Sponsor: Investigators at the Centers for Disease Control and Prevention contributed to the design and conduct of the study. Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by Institutional Review Boards at Vanderbilt University Medical Center and Marshfield Clinic Health System. The Centers for Disease Control and Prevention (CDC) determined this activity was conducted consistent with applicable federal law and CDC policy (see 45 C.F.R. part 46; 21 C.F.R. part 56).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of Interest Disclosures: NBH reports grants from Sanofi and Quidel. CGG reports grants from Campbell Alliance/Syneos, the National Institutes of Health, the Food and Drug Administration, the Agency for Health Care Research and Quality and Sanofi-Pasteur, and consultation fees from Pfizer, Merck, and Sanofi-Pasteur. Other authors have no conflicts of interest relevant to this article to disclose.

  • Funding/Support: This study was supported by the Centers for Disease Control and Prevention, (cooperative agreements IP001078 and IP001083). Dr. Grijalva was supported in part by the National Institute for Allergy and Infectious Diseases (K24 AI148459). The work used REDCap, which is supported by CTSA award No. UL1 TR002243 from the National Center for Advancing Translational Sciences.

  • Role of Funder/Sponsor: Investigators at the Centers for Disease Control and Prevention contributed to the design and conduct of the study.

  • Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.

Data Availability

De-identified dataset can be made available upon request

  • Abbreviations

    CDC
    Centers for Disease Control and Prevention
    CI
    Confidence interval
    GEE
    General estimating equations
    IQR
    Interquartile range
    MCHS
    Marshfield Clinic Health System
    OR
    Odds ratio
    RR
    Risk ratio
    rRT-PCR
    Real-time reverse transcription polymerase chain reaction
    SD
    Standard deviation
    SIR
    Secondary infection risk
    US
    United States
    VUMC
    Vanderbilt University Medical Center
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted August 18, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Household Transmission and Clinical Features of SARS-CoV-2 Infections by Age in 2 US Communities
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Household Transmission and Clinical Features of SARS-CoV-2 Infections by Age in 2 US Communities
    Huong Q. McLean, Carlos G. Grijalva, Kayla E. Hanson, Yuwei Zhu, Jessica E. Deyoe, Jennifer K. Meece, Natasha B. Halasa, James D. Chappell, Alexandra Mellis, Carrie Reed, Edward A. Belongia, H. Keipp Talbot, Melissa A. Rolfes
    medRxiv 2021.08.16.21262121; doi: https://doi.org/10.1101/2021.08.16.21262121
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Household Transmission and Clinical Features of SARS-CoV-2 Infections by Age in 2 US Communities
    Huong Q. McLean, Carlos G. Grijalva, Kayla E. Hanson, Yuwei Zhu, Jessica E. Deyoe, Jennifer K. Meece, Natasha B. Halasa, James D. Chappell, Alexandra Mellis, Carrie Reed, Edward A. Belongia, H. Keipp Talbot, Melissa A. Rolfes
    medRxiv 2021.08.16.21262121; doi: https://doi.org/10.1101/2021.08.16.21262121

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (161)
    • Allergy and Immunology (416)
    • Anesthesia (91)
    • Cardiovascular Medicine (860)
    • Dentistry and Oral Medicine (159)
    • Dermatology (97)
    • Emergency Medicine (250)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
    • Epidemiology (8562)
    • Forensic Medicine (4)
    • Gastroenterology (384)
    • Genetic and Genomic Medicine (1753)
    • Geriatric Medicine (167)
    • Health Economics (373)
    • Health Informatics (1244)
    • Health Policy (621)
    • Health Systems and Quality Improvement (468)
    • Hematology (196)
    • HIV/AIDS (374)
    • Infectious Diseases (except HIV/AIDS) (10303)
    • Intensive Care and Critical Care Medicine (553)
    • Medical Education (192)
    • Medical Ethics (51)
    • Nephrology (212)
    • Neurology (1678)
    • Nursing (97)
    • Nutrition (251)
    • Obstetrics and Gynecology (326)
    • Occupational and Environmental Health (451)
    • Oncology (929)
    • Ophthalmology (263)
    • Orthopedics (102)
    • Otolaryngology (172)
    • Pain Medicine (114)
    • Palliative Medicine (40)
    • Pathology (253)
    • Pediatrics (536)
    • Pharmacology and Therapeutics (253)
    • Primary Care Research (208)
    • Psychiatry and Clinical Psychology (1770)
    • Public and Global Health (3841)
    • Radiology and Imaging (624)
    • Rehabilitation Medicine and Physical Therapy (320)
    • Respiratory Medicine (520)
    • Rheumatology (208)
    • Sexual and Reproductive Health (168)
    • Sports Medicine (158)
    • Surgery (190)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (76)